Barbara Davis Center for Childhood Diabetes

What Barbara Davis Center for Childhood Diabetes does

The Barbara Davis Center for Childhood Diabetes is a specialized type 1 diabetes care and research center operating as a department within the University of Colorado Anschutz Medical Campus School of Medicine, governed by The Regents of the University of Colorado. It provides clinical care across four specialty clinics—Pediatric, Adult, Eye, and Early T1D—serving children, adolescents, and adults with type 1 diabetes through on-site appointments, outreach telemedicine clinics, and e-Consult services for external providers. The center also operates the STOP-T1D autoantibody screening program to identify at-risk individuals and an Early T1D Clinic for recently diagnosed patients.

The center's research operations are organized into four divisions (Basic and Translational Research, Diabetes Research Center, Clinical Research, and Clinical Epidemiology) and supported by four core laboratory facilities: Autoantibody/HLA testing, Tissue Procurement and Processing, Cell and Tissue Analysis, and Molecular Biology. These facilities provide specialized infrastructure for diabetes research and clinical trial activity. The center is led by Executive Director Marian Rewers, MD, PhD, and is closely affiliated with Children's Hospital Colorado (sharing campus and IT infrastructure including the MyChart patient portal) and the Children's Diabetes Foundation, which provides significant philanthropic support.

Revenue is generated through professional clinical services billed to insurers and patients, supplemented by research grants and philanthropic donations. The center operates as a state-supported public institution, not a venture-backed or publicly traded entity, with no disclosed pricing, revenue figures, or funding rounds. Its value proposition rests on combining clinical excellence with cutting-edge research, access to clinical trials, and specialized expertise in type 1 diabetes across the lifespan.

Name

Barbara Davis Center for Childhood Diabetes

Legal name

The Regents of the University of Colorado

Website

https://barbaradaviscenter.org

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Short description

The Barbara Davis Center for Childhood Diabetes is a University of Colorado Anschutz academic center providing specialized type 1 diabetes clinical care, screening, and translational research across pediatric, adult, and eye clinics, supported by dedicated core laboratory facilities.

Ownership category

akta.pro rank

Product category

Specialty Diabetes Care and Research

NAICS

Offices of Physicians (62111), Offices of Physicians (6211)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Type 1 Diabetes Care (HLAKADAB)

akta.pro secondary industry

Diabetes (General) (HLAKADAA)

Keywords

• Type 1 diabetes care
• Diabetes research
• Pediatric endocrinology
• Clinical trials diabetes
• Autoantibody screening

Headquarters

HQ city

Aurora

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Others

Revenue model

1. Healthcare Services Revenue: Revenue generated from providing clinical care services to patients with type 1 diabetes across pediatric, adult, and specialty eye clinics. Services are billed through standard healthcare insurance and payment mechanisms.
2. Research Funding and Grants: The center receives research funding through grants and philanthropy to support its diabetes research mission, including basic and translational research, clinical research, and diabetes prevention initiatives.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels2 records

Core offering

The Barbara Davis Center for Diabetes provides specialized clinical care and research services for type 1 diabetes across the lifespan. It operates Pediatric, Adult, Eye, and Early T1D clinics, offers autoantibody screening through the STOP-T1D program, and supports research through four divisions (Basic and Translational Research, Diabetes Research Center, Clinical Research, and Clinical Epidemiology) backed by four core laboratories. It is part of the University of Colorado Anschutz Medical Campus and closely affiliated with the Children's Diabetes Foundation.

Product overview

The Barbara Davis Center is a specialized diabetes care and research center at the University of Colorado Anschutz Medical Campus, providing a comprehensive suite of clinical services for type 1 diabetes patients across the lifespan. The center operates multiple specialty clinics including Pediatric, Adult, Eye, and Early T1D clinics, supported by advanced autoantibody testing and screening programs. Research operations are organized into Basic and Translational Research, Diabetes Research Center, Clinical Research, and Clinical Epidemiology divisions, each contributing to understanding, prevention, and treatment of diabetes. Core laboratory facilities support this research mission with specialized services in autoantibody/HLA testing, tissue processing, cell and tissue analysis, and molecular biology. The center also provides e-consultation services for external providers and operates outreach clinics via telemedicine to extend specialized diabetes care beyond the main campus.

Differentiator

Problem solved

Functional benefit

Products and services

• Pediatric Clinic Specialized type 1 diabetes care clinic for children and adolescents, providing diagnosis, treatment, education, and ongoing disease management for pediatric patients.
• Adult Clinic Specialized type 1 diabetes care clinic for adult patients, offering continuous care, treatment, and management services across the lifespan.
• Eye Clinic Ophthalmology clinic specializing in diabetes-related eye complications, providing screening and treatment for diabetic retinopathy and other diabetes-associated eye conditions.
• Early T1D Clinic Specialized clinic for patients recently diagnosed with type 1 diabetes, providing early intervention, education, and disease management services.
• Autoantibody Testing (STOP-T1D) Screening service for autoantibodies to identify individuals at risk for developing type 1 diabetes, delivered as part of the STOP-T1D program.
• Basic and Translational Research Division Research division focused on fundamental scientific investigation of diabetes mechanisms, disease progression, and potential therapeutic interventions.
• Diabetes Research Center Comprehensive diabetes research center dedicated to understanding diabetes pathophysiology and developing novel treatment approaches.
• Clinical Research Division Division conducting clinical trials and human studies to evaluate new diabetes treatments, devices, and management strategies.
• Clinical Epidemiology Division Research division studying the distribution and determinants of diabetes in populations to inform prevention and treatment strategies.
• Autoantibody/HLA Core Facility Core laboratory facility providing autoantibody and HLA (human leukocyte antigen) testing services for diabetes research and clinical purposes.
• Tissue Procurement and Processing Core Facility Core facility for obtaining, processing, and preserving biological tissue samples for diabetes research.
• Cell and Tissue Analysis Core Facility Core facility providing advanced cellular and tissue analysis services including islet isolation and characterization for diabetes research.
• Molecular Biology Core Facility Core facility offering molecular biology services including gene expression analysis, sequencing, and other molecular techniques for diabetes research.
• e-Consults Electronic consultation service allowing external and referring providers to submit asynchronous interprofessional consultations for established patients or second opinions.
• Outreach Telemedicine Clinics Remote clinical services bringing type 1 diabetes care to patients in Grand Junction and other underserved areas through telemedicine clinics.

Segments2 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered core.

• Children's Hospital ColoradocoreStrategic or Co-development PartnerAffiliated with Children's Hospital Colorado, sharing the same healthcare campus and collaborating on pediatric patient care. The center's MyChart patient portal is hosted on Children's Colorado's systems, indicating integrated healthcare information technology infrastructure.
• University of Colorado Anschutz Medical CampuscoreStrategic or Co-development PartnerThe Barbara Davis Center is an academic department within the University of Colorado Anschutz Medical Campus, benefiting from institutional resources, accreditation, and integration with other medical school departments including Schools of Dental Medicine, Nursing, Pharmacy, and Public Health.

Scale indicators1 record

Recent moves5 records

Expansion highlights4 records

Direct peers

• Joslin Diabetes Center: Harvard-affiliated specialty diabetes center offering integrated clinical care, research, and education across all forms of diabetes. Directly comparable to BDC in mission, clinical model, and research orientation, with a longer national brand history.
• Stanford Diabetes Research Center: Stanford School of Medicine center combining clinical research and basic science in T1D and T2D. Comparable to BDC in research-driven model with cross-disciplinary programs and NIH-funded center status.
• Vanderbilt Diabetes Research and Training Center: NIDDK-funded Diabetes Research Center at Vanderbilt providing translational research, clinical care, and training. Comparable to BDC as an NIH-designated specialty center with overlapping clinical and research missions.
• Naomi Berrie Diabetes Center: Columbia University-affiliated diabetes center combining pediatric and adult T1D care with translational research. Comparable operating model and patient mix to BDC, with a strong research footprint in immunology and beta-cell biology.
• University of Michigan Caswell Diabetes Institute: University of Michigan-wide institute integrating T1D and T2D clinical care, research, and training. Comparable to BDC in academic structure, multi-disciplinary clinical services, and a strong bench-to-bedside orientation.
• Diabetes Research Institute (DRI) at the University of Miami: University of Miami Miller School of Medicine center focused on curing T1D through islet transplantation and beta-cell regeneration. Comparable to BDC in combining clinical care with a dedicated diabetes research mission and high-profile translational programs.

Broad incumbents

• Medtronic Diabetes: Major manufacturer of insulin pumps and automated insulin delivery systems. Adjacent to BDC's clinical and research operations; a likely trial sponsor and device partner rather than a direct competitor.
• Dexcom: Continuous glucose monitoring market leader. Not a direct service competitor to BDC, but a device partner whose CGM data is integral to BDC's clinical care and research workflows.

Others

• JDRF (formerly Juvenile Diabetes Research Foundation): Largest non-profit funder of T1D research globally. Not a direct competitor but a critical funding partner and ecosystem player for any academic T1D center, including BDC.
• TrialNet: International network conducting T1D screening and prevention trials. Related ecosystem participant that collaborates with centers like BDC on autoantibody screening and prevention studies such as STOP-T1D.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/barbaradavisctr
• LinkedInlinkedin.com/company/barbara-davis-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Barbara Davis Center for Childhood Diabetes